Status:
COMPLETED
An End-to-end System for Assessment and Intervention of Frailty
Lead Sponsor:
Tan Tock Seng Hospital
Collaborating Sponsors:
Nanyang Technological University
Conditions:
Frailty
Eligibility:
All Genders
60-90 years
Phase:
NA
Brief Summary
The study aims to evaluate the feasibility and effectiveness of using SAIF (an end-to-end System for Assessment and Intervention of Frailty) to reduce the risk and delay the progress of physical frail...
Detailed Description
SAIF is a personalised, community-based system for both assessment and intervention of frailty. It comprises of 8 modules categorised into 1. Interface: virtual nurse and caregiver gateway 2. Assessm...
Eligibility Criteria
Inclusion
- Age 60 and above
- CFS 4 or 5 / CFS 3 with FRAIL score at least 1 / CFS 3 with FPQ score at least 1
- Ambulate for at least 10m without walking aid
- English and/or Mandarin speaking
Exclusion
- Known diagnosis of dementia or CMMSE score \<19
- Parkinson's disease
- Hip surgery within the last 6 months
- Presence of end-stage organ failure, symptomatic heart conditions or COPD
- Active arthritis
- Hospitalisation within the last 1 month
- Participants who are unable to provide consent
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 16 2022
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT05371210
Start Date
March 15 2021
End Date
June 16 2022
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tan Tock Seng Hospital
Singapore, Singapore, Singapore, 308433